ESC Premium Access

Culprit-plaque morphology and residual SYNTAX score for predicting cardiovascular events in acute myocardial infarction: an optical coherence tomography study

Congress Session

About the speaker

Doctor Ying Wang

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
0 follower

4 more presentations in this session

Prevalence, predictors, and clinical prognosis of macrophage infiltrates in patients with ST-segment elevation myocardial infarction caused by plaque erosion as assessed by OCT

Speaker: Doctor C. Zhao (Harbin, CN)

Thumbnail

Prognostic implications of cholesterol chrystals at ACS causing culprit lesions, insights from the translational OPTICO-ACS study program

Speaker: Mr G. Nelles (Berlin, DE)

Thumbnail

Long-term follow-up of patients with MINOCA (myocardial infarction with unobstructed coronary arteries) undergoing intracoronary spasm provocation testing

Speaker: Doctor G. Pirozzolo (Stuttgart, DE)

Thumbnail

Gender differences in the impact of plasma xanthine oxidoreductase activity on coronary artery spasm

Speaker: Doctor K. Watanabe (Yamagata, JP)

Thumbnail

Access the full session

Acute coronary syndromes pathophysiology and mechanisms: what's new?

Speakers: Doctor Y. Wang, Doctor C. Zhao, Mr G. Nelles, Doctor G. Pirozzolo, Doctor K. Watanabe
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: case presentation.

27 August 2021

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

This platform is supported by

logo Novo Nordisk